APA

Shoshan M. C., Havelka A. P. P. I. A. M., Neumann F. & Linder S. (20130320). Sense and sensibility: the use of cell death biomarker assays in high-throughput anticancer drug screening and monitoring treatment responses. : Expert opinion on drug discovery.

Chicago

Shoshan Maria C, Havelka Associate Professor Principal Investigator Aleksandra Mandic, Neumann Frank and Linder Stig. 20130320. Sense and sensibility: the use of cell death biomarker assays in high-throughput anticancer drug screening and monitoring treatment responses. : Expert opinion on drug discovery.

Harvard

Shoshan M. C., Havelka A. P. P. I. A. M., Neumann F. and Linder S. (20130320). Sense and sensibility: the use of cell death biomarker assays in high-throughput anticancer drug screening and monitoring treatment responses. : Expert opinion on drug discovery.

MLA

Shoshan Maria C, Havelka Associate Professor Principal Investigator Aleksandra Mandic, Neumann Frank and Linder Stig. Sense and sensibility: the use of cell death biomarker assays in high-throughput anticancer drug screening and monitoring treatment responses. : Expert opinion on drug discovery. 20130320.